MakZak, You seem to call people out quite a bit. Do you

New Post Public Reply Private Reply Replies (2) Message Board
Florida Girl
391
MakZak,

You seem to call people out quite a bit. Do you want others to call you out?

I keep reading all of these names, and I quote:

“I would have to agree after reading the last Q its clear we were all lied to by TPACMuse/IR/S7/S1/James Brown/IR.”

TPAC has been flat broke from 2007 to 2014. I did my DD. Following the names you used in the information you provided, I didn’t see their presence when TPAC was at the .0072 spike. If you bought shares in 2014, you did it based on information that was coming directly from CEO Bill McKay. TPAC was broke, had no financial stability and actually stated that they didn’t know how they were going to keep the doors open. Why are you trying to blame a group of people who didn’t even exist in TPAC world at the time? You bought on speculation and forward guidance from Bill, not the group you mentioned.

Secondly, I saw people ask questions to MUSE about forward guidance several times, and I’ve seen where IR Manager James couldn’t give forward guidance because there was no manufacturing facility. It’s simple, no facility -no operation.

I researched the financials in the Q and K up 2017 and found there were no contracts with income of $200k and at the point of the .0072 spike, there was less than $3,900 in the bank with almost a 4 billion outstanding shares and another 2.5 billion in preferred waiting for maturity or to be converted to common shares.

Next, I saw another 1.5 billion outstanding shares for payday loans; again none of this was created by anyone of the ones that you keep blaming TPACMuse/IR/S7/S1/James Brown/IR. They were a new service.

I don’t understand why you consistently blame these people instead of the CEO, who issued the preferred shares, provided speculation and forward guidance. It appears that even the $109K PO was removed from his financials. You seem to talk around all of this and try to blame other people. Remember, I’m following your words and following what you say happened. I clearly see a different story. Oh and by the way, I also saw where Bill McKay himself called you a liar.

Also, your account was created November 1, 2017 and you continue to talk about things that happened way before then. The account was also created after TPAC reached a no bid status. You are Carson, nosheeplehere, smalls, smallsv2 and Lord only knows how many other aliases. Most of which has been banned from the board until further notice. Stop trying to mislead shareholders. If the CEO himself called you a liar, no one else will believe you.

I have also examined the TPAC FIC. Guess what? It works.
1

Trans-Pacific Aerospace (TPAC) Stock Research Links

TPAC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 3

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 4

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 4

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading

Top 5 Most Recently Viewed Articles

Alphabet Surprises with Strong Earnings, Stocks React Mixed

Updated Category News Views 160

Market Overview: Nasdaq Decline and Mixed Results U.S. stocks experienced a mixed trading session, with the Nasdaq Composite registering a notable drop of over 1% recently. The trading began with the Dow Jones Industrial Average slightly up by 0.03%, reaching 47,644.08, while the Nasdaq decreased by 1.13% to settle at 23,687.37. Similarly, the S&P 500 index fell by 0.63%,...

Continue Reading
FTI Consulting Welcomes Antitrust Expert Dr. William Rogerson

Updated Category News Views 261

FTI Consulting Expands Expertise with Dr. William Rogerson In an exciting move, FTI Consulting, Inc. (NYSE: FCN) has announced that Dr. William Rogerson has joined its subsidiary Compass Lexecon, marking a significant enhancement to their consulting capabilities, especially in the arenas of competition and antitrust. About Dr. William Rogerson Dr. Rogerson is renowned for...

Continue Reading
Coop Pank's July 2025 Financial Insights and Growth Strategies

Updated Category News Views 217

Coop Pank’s Impressive Financial Performance In July 2025, Coop Pank demonstrated remarkable growth in its client base and financial metrics. With an increase of 1,700 clients, the total number of bank clients reached 219,300, while active clients grew by 600 to a total of 104,100. This 11% increase in the customer base over the year highlights the bank’s successful...

Continue Reading
Gordon Johnson Labels Crypto Market as Corrupt Amid Trump Plan

Updated Category News Views 289

Gordon Johnson Criticizes Market Integrity Gordon Johnson, an analyst at GLJ Research, recently made headlines with his statements on the cryptocurrency market. He expressed concerns over what he described as rampant market 'corruption' following President Donald Trump’s announcement regarding a strategic U.S. cryptocurrency reserve. This reserve is set to include...

Continue Reading
Custom Veterinary and Green Mountain Join Forces for Pet Wellness

Updated Category News Views 252

Custom Veterinary Joins Forces with Green Mountain Animal Custom Veterinary Services, a platform supported by Align Capital Partners, has taken a significant step in the pet health industry by acquiring Green Mountain Animal, LLC. This strategic acquisition marks a pivotal moment for both companies as they look to enhance their offerings and services in the pet health...

Continue Reading